Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
0.00%
+0.49%
+0.94%
-2.97%
-1.83%
PFE
Pfizer
$23.88
Chart
$22.97 (+3.96%)
$25.22 (-5.31%)
$25.22 (-5.31%)
$28.05 (-14.87%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
0.00%
+0.49%
+0.94%
-2.97%
-1.83%
PFE
Pfizer
Current Price
$23.88
Login to view Pfizer (PFE) recommendation from the last 90 days from financial news and social media.
Chart
$22.97 (+3.96%)
$25.22 (-5.31%)
$25.22 (-5.31%)
$28.05 (-14.87%)
PFE Latest Analysis
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE). Berger Montague advises shareholders of Pfizer Inc. (Pfizer or the Company) (NYSE:) about an investigation into Pfizer'.s Board of Directors for potential breaches of fiduciary duties to Pfizer and its shareholders in connection with the Company'.s marketing and sale of Depo-Provera.Shareholders of PFIZER may learn more about this investigation by contacting Be
Thu Jun 12, 2025
Why Moderna Stock Is Crumbling. Moderna’.s stock (NASDAQ: MRNA) has plummeted over 80% in the past year largely due to challenges in its vaccine sales. Last year the company announced lower sales projections in Europe following the European Union’.s renegotiated vaccine supply contract with Pfizer a
Wed Jun 11, 2025
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To Restore Public Trust — Pfizer Moderna Other Biotech Stocks Drop In After-Hours Trading. On Monday the United States Secretary of Health and Human Services published in the Wall Street Journal Kennedy said that this clean sweep was necessary in order to “.re-establish public confidence in vaccine science.”. He argued that the current panel had become a “.rubber stamp for any vaccine”. and was compromised by “.persistent
Tue Jun 10, 2025
Pfizer: Dividend Investors Dream And Patent Cliff Nightmare.
Tue Jun 10, 2025
Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip?. PFE lags the market as COVID sales drop and patent losses loom but new drugs and cost cuts may fuel a comeback.
Mon Jun 9, 2025
Pfizer Inc. (PFE) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript.
Mon Jun 9, 2025
Pfizer To Present At Goldman Sachs Global Healthcare Conference. Webcast At 8:00 AM ET . (RTTNews) - Pfizer Inc. (PFE) will present at Goldman Sachs 46th Annual Global Healthcare Conference
Mon Jun 9, 2025
Nanotechnology in Cancer Treatment Market Positioned for Transformational Growth by 2029. Boston June 05 2025 (GLOBE NEWSWIRE) -- As cancer prevalence continues to rise globally nanotechnology in cancer treatment is emerging as a transformative force in oncology. Leveraging nanoscale drug delivery systems and precision-targeting techniques companies such as AstraZeneca F. Hoffmann-La Roche Ltd. and Bristol-Myers Squibb are developing next-generation solutions to enhance therapeutic effectiveness
Thu Jun 5, 2025
Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight. Global Antidote Market to Cross the USD 4 Billion Mark by 2032 |. DelveInsightThe antidote market is witnessing substantial growth largely propelled by the growing incidence of poisoning drug overdoses and snake or animal bites. This rising demand is supported by greater public health awareness government efforts to combat drug overdoses and continuous progress in product innovation. Moreover strategic product lau
Thu Jun 5, 2025
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE). PHILADELPHIA June 3 2025 /PRNewswire/ -- Berger Montague advises shareholders of Pfizer Inc. (Pfizer or the Company) (NYSE: PFE) about an investigation into Pfizers Board of Directors for potential breaches of fiduciary duties to Pfizer and its shareholders in connection with the...
Tue Jun 3, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
